IP Library › Granted Patent US 12,337,031
Granted Patent B2
US 12,337,031 · App. 17/590,173 · Granted Jun 24, 2025

Combination vaccine

Inventors: Karl-Josef Kallen (Königsdorf, DE); Thomas Kramps (Tübingen, DE); Margit Schnee (Constance, DE); Daniel Voss (Tübingen, DE)
Assignee: CureVac SE
A61K39/155A61K39/12A61K39/145C07K14/005C12N7/00A61K2039/53A61K2039/572A61K2039/575C12N2760/16134C12N2760/18534
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,337,031
App. No.
17/590,173
Granted
Jun 24, 2025
Kind
B2
Abstract

The present invention relates to a vaccine, especially a combination vaccine providing at least a first and a second antigenic function, the combination vaccine comprising at least one RNA encoding at least one or more proteins or fragments, variants or derivatives of proteins awarding antigenic function, wherein the first antigenic function being a Fusion (F) protein or a fragment, variant or derivative of a Fusion (F) protein derived from the virus family Paramyxoviridae and the second antigenic function being an Hemagglutinin (HA) protein or a fragment, variant or derivative of an Hemagglutinin (HA) protein derived from the virus family Orthomyxoviridae. Furthermore, the present invention is directed to a kit or kit of parts comprising the components of said combination vaccine and to said combination vaccine for use in a method of prophylactic or therapeutic treatment of diseases, particularly in the prevention or treatment of infectious diseases like RSV and influenza.

Claims (26)

1. A cytotoxic T cell-inducing immunogenic composition comprising:

i) at least a first mRNA comprising a protein coding sequence encoding at least the extracellular domain of a human respiratory syncytial virus (RSV) Fusion protein (F) antigen, said RSV-F antigen comprising an amino acid sequence encoding the T-cell epitopes of SEQ ID NOs: 24, 25 and 26; and

ii) at least a second mRNA comprising a protein coding sequence encoding at least the extracellular domain of a human influenza virus Hemagglutinin (HA) protein.

2. The immunogenic composition of claim 1 , wherein the first and second mRNAs comprise 5′ Cap structures.

3. The immunogenic composition of claim 2 , wherein the first and second mRNAs comprise poly-A sequence of about 50 to about 250 adenosine nucleotides.

4. The immunogenic composition of claim 3 , wherein the first and second mRNAs comprise 5′ and/or 3′ UTR sequences.

5. The immunogenic composition of claim 4 , wherein the protein coding sequence of the first and second mRNAs is modified to increase the G/C content.

6. The immunogenic composition of claim 4 , wherein the first and second mRNAs are complexed with a cationic or polycationic compound.

7. The immunogenic composition of claim 6 , wherein the first and second mRNAs are complexed with a cationic or polycationic protein.

8. The immunogenic composition of claim 6 , wherein the first and second mRNAs are complexed with a cationic lipid.

9. The immunogenic composition of claim 4 , wherein the HA protein is a full-length HA protein.

10. The immunogenic composition of claim 4 , wherein the F protein is a full-length HA protein.

11. The immunogenic composition of claim 4 , wherein the HA protein is an Influenza A HA protein.

12. The immunogenic composition of claim 11 , wherein the Influenza A HA protein is from H1N1, H1N2, H3N1, H3N2, H3N8, H5N1, H5N2, H5N3, H5N8, H5N9, H7N1, H7N2, H7N3, H7N4, H7N7, H9N1, H9N2 or H10N7 Influenza.

13. The immunogenic composition of claim 12 , wherein the Influenza A HA protein is H1 HA protein.

14. The immunogenic composition of claim 4 , wherein the HA protein is an Influenza B HA protein.

15. The immunogenic composition of claim 4 , wherein the composition comprises a further mRNA encoding a further antigen.

16. The immunogenic composition of claim 15 , wherein the further antigen is an Influenza HA protein.

17. The immunogenic composition of claim 5 , wherein the first and second mRNAs are complexed with a cationic lipid.

18. The immunogenic composition of claim 17 , wherein the HA protein is an Influenza A HA protein.

19. The immunogenic composition of claim 18 , wherein the HA protein is a full-length HA protein.

20. The immunogenic composition of claim 17 , wherein the first mRNA encodes a RSV F protein comprising least the extracellular domain and the transmembrane domain of the RSV F protein.

21. The immunogenic composition of claim 4 , wherein the HA protein is from a H1N1 virus.

22. The immunogenic composition of claim 21 , wherein upon intradermal or intramuscular injection to a mammal the composition induces a cytotoxic T cell response to the amino acid epitope of SEQ ID NOs: 24, 25 and/or 26.

23. The immunogenic composition of claim 22 , wherein upon intradermal or intramuscular injection to a mammal the composition induces a cytotoxic T cell response to the amino acid epitope of SEQ ID NO: 24.

24. The immunogenic composition of claim 22 , wherein the first and second mRNAs are complexed with a cationic or polycationic compound.

Assignments (1)
CHANGE OF NAME Recorded Feb 18, 2023
From: CUREVAC AG
To: CUREVAC SE
Reel/Frame 062799/0268 →
Continuity (4)
Division 16781781 · Feb 4, 2020
Division 15048561 · Feb 19, 2016
Continuation PCTEP2014002302 · Aug 21, 2014
Related Publication 20220152193A1 · May 19, 2022
References Cited (306)
US 8217016B2 · Hoerr et al. · 2012 [cited by applicant]
US 8383340B2 · Ketterer et al. · 2013 [cited by applicant]
US 8703906B2 · Baumhof et al. · 2014 [cited by applicant]
US 8968746B2 · Baumhof et al. · 2015 [cited by applicant]
US 9155788B2 · Hoerr et al. · 2015 [cited by applicant]
US 9226959B2 · Kramps et al. · 2016 [cited by applicant]
US 9234013B2 · Thess et al. · 2016 [cited by applicant]
US 9314535B2 · Baumhof et al. · 2016 [cited by applicant]
US 9352028B2 · Barner et al. · 2016 [cited by applicant]
US 9402887B2 · Probst et al. · 2016 [cited by applicant]
US 9421255B2 · Baumhof et al. · 2016 [cited by applicant]
US 9433669B2 · Hoerr et al. · 2016 [cited by applicant]
US 9433670B2 · Hoerr et al. · 2016 [cited by applicant]
US 9439956B2 · Hoerr et al. · 2016 [cited by applicant]
US 9447431B2 · Thess et al. · 2016 [cited by applicant]
US 9463228B2 · Hoerr et al. · 2016 [cited by applicant]
US 9572874B2 · Fotin-Mleczek et al. · 2017 [cited by applicant]
US 9616084B2 · Mutzke · 2017 [cited by applicant]
US 9623095B2 · Kallen et al. · 2017 [cited by applicant]
US 9655955B2 · Hoerr et al. · 2017 [cited by applicant]
US 9669089B2 · Thess et al. · 2017 [cited by applicant]
US 9683233B2 · Thess · 2017 [cited by applicant]
US 9688729B2 · Kramps et al. · 2017 [cited by applicant]
US 9737595B2 · Lorenz et al. · 2017 [cited by applicant]
US 9839697B2 · Thess et al. · 2017 [cited by applicant]
US 9890391B2 · Thess et al. · 2018 [cited by applicant]
US 9907862B2 · Baumhof et al. · 2018 [cited by applicant]
US 9974845B2 · Fotin-Mleczek et al. · 2018 [cited by applicant]
US 10010592B2 · Thess et al. · 2018 [cited by applicant]
US 10017826B2 · von der Mülbe et al. · 2018 [cited by applicant]
US 10047375B2 · Thess · 2018 [cited by applicant]
US 10080809B2 · Thess · 2018 [cited by applicant]
US 10111967B2 · Fotin-Mleczek et al. · 2018 [cited by applicant]
US 10111968B2 · Thess et al. · 2018 [cited by applicant]
US 10117920B2 · Fotin-Mleczek et al. · 2018 [cited by applicant]
US 10150797B2 · Kramps et al. · 2018 [cited by applicant]
US 10166283B2 · Thess et al. · 2019 [cited by applicant]
US 10172935B2 · Kallen et al. · 2019 [cited by applicant]
US 10188748B2 · von der Mülbe et al. · 2019 [cited by applicant]
US 10232024B2 · Thess et al. · 2019 [cited by applicant]
US 10293058B2 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 10293060B2 · Baumhof · 2019 [cited by applicant]
US 10307472B2 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 10369216B2 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 10434154B2 · Probst et al. · 2019 [cited by applicant]
US 10434158B2 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 10441653B2 · Hoerr et al. · 2019 [cited by applicant]
US 10501768B2 · Eber et al. · 2019 [cited by applicant]
US 10517827B2 · Eber et al. · 2019 [cited by applicant]
US 10568958B2 · Baumhof et al. · 2020 [cited by applicant]
US 10568972B2 · von der Mülbe et al. · 2020 [cited by applicant]
US 10588959B2 · Kallen et al. · 2020 [cited by applicant]
US 10596252B2 · Kallen et al. · 2020 [cited by applicant]
US 10610605B2 · Thess et al. · 2020 [cited by applicant]
US 10648017B2 · Wochner · 2020 [cited by applicant]
US 10653768B2 · Mutzke et al. · 2020 [cited by applicant]
US 10653799B2 · Thess et al. · 2020 [cited by applicant]
US 10682406B2 · Thess et al. · 2020 [cited by applicant]
US 10682426B2 · Schnee et al. · 2020 [cited by applicant]
US 10711315B2 · von der Mülbe et al. · 2020 [cited by applicant]
US 10729654B2 · Eber et al. · 2020 [cited by applicant]
US 10729761B2 · Kallen et al. · 2020 [cited by applicant]
US 10738306B2 · Thess · 2020 [cited by applicant]
US 10751424B2 · Baumhof et al. · 2020 [cited by applicant]
US 10760070B2 · Funkner et al. · 2020 [cited by applicant]
US 10780054B2 · Ketterer et al. · 2020 [cited by applicant]
US 10799577B2 · Thess et al. · 2020 [cited by applicant]
US 10799602B2 · Baumhof · 2020 [cited by applicant]
US 10837039B2 · Wochner et al. · 2020 [cited by applicant]
US 10869935B2 · Fotin-Mleczek et al. · 2020 [cited by applicant]
US 10898584B2 · Schlake et al. · 2021 [cited by applicant]
US 10898589B2 · Thess et al. · 2021 [cited by applicant]
US 10912826B2 · Thess et al. · 2021 [cited by applicant]
US 10918740B2 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 10988754B2 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 11034729B2 · Kramps et al. · 2021 [cited by applicant]
US 11078247B2 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 11110156B2 · Thess et al. · 2021 [cited by applicant]
US 11110157B2 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 11110166B2 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 11135312B2 · von der Mülbe et al. · 2021 [cited by applicant]
US 11141474B2 · Rauch et al. · 2021 [cited by applicant]
US 11141476B2 · Rauch · 2021 [cited by applicant]
US 11149278B2 · Thess et al. · 2021 [cited by applicant]
US 11179337B2 · Eber et al. · 2021 [cited by applicant]
US 11225682B2 · Reichert et al. · 2022 [cited by applicant]
US 11241493B2 · Rauch et al. · 2022 [cited by applicant]
US 11248223B2 · Yazdan Panah et al. · 2022 [cited by applicant]
US 11254951B2 · Thess · 2022 [cited by applicant]
US 11266735B2 · Kallen et al. · 2022 [cited by applicant]
US 11268157B2 · von der Mülbe et al. · 2022 [cited by applicant]
US 11274293B2 · Funkner et al. · 2022 [cited by applicant]
US 11279923B2 · Funkner et al. · 2022 [cited by applicant]
US 11286492B2 · Thess et al. · 2022 [cited by applicant]
US 20050032730A1 · Von der Mulbe et al. · 2005 [cited by applicant]
US 20050059624A1 · Hoerr et al. · 2005 [cited by applicant]
US 20050250723A1 · Hoerr et al. · 2005 [cited by applicant]
US 20060188490A1 · Hoerr et al. · 2006 [cited by applicant]
US 20070280929A1 · Hoerr et al. · 2007 [cited by applicant]
US 20080025944A1 · Hoerr et al. · 2008 [cited by applicant]
US 20080171711A1 · Hoerr et al. · 2008 [cited by applicant]
US 20080267873A1 · Hoerr et al. · 2008 [cited by applicant]
US 20090324584A1 · Hoerr et al. · 2009 [cited by applicant]
US 20100047261A1 · Hoerr et al. · 2010 [cited by applicant]
US 20100048883A1 · Ketterer et al. · 2010 [cited by applicant]
US 20100189729A1 · Hoerr et al. · 2010 [cited by applicant]
US 20100203076A1 · Fotin-Mleczek et al. · 2010 [cited by applicant]
US 20100291156A1 · Barner et al. · 2010 [cited by applicant]
US 20100305196A1 · Probst et al. · 2010 [cited by applicant]
US 20110053829A1 · Baumhof et al. · 2011 [cited by applicant]
US 20110250225A1 · Fotin-Mleczek et al. · 2011 [cited by applicant]
US 20120021043A1 · Kramps et al. · 2012 [cited by applicant]
US 20120258046A1 · Mutzke · 2012 [cited by applicant]
US 20130129754A1 · Thess et al. · 2013 [cited by applicant]
US 20130142818A1 · Baumhof et al. · 2013 [cited by applicant]
US 20130195867A1 · Hoerr et al. · 2013 [cited by applicant]
US 20130202645A1 · Barner et al. · 2013 [cited by applicant]
US 20130251742A1 · Probst et al. · 2013 [cited by applicant]
US 20130259879A1 · Baumhof et al. · 2013 [cited by applicant]
US 20130280283A1 · Lorenz et al. · 2013 [cited by applicant]
US 20130295043A1 · Kallen et al. · 2013 [cited by applicant]
US 20130336998A1 · Kallen et al. · 2013 [cited by applicant]
US 20150037326A1 · Butler-Ransohoff et al. · 2015 [cited by applicant]
US 20150050302A1 · Thess · 2015 [cited by applicant]
US 20150057340A1 · Thess et al. · 2015 [cited by applicant]
US 20150093413A1 · Thess et al. · 2015 [cited by applicant]
US 20150118183A1 · Baumhof · 2015 [cited by applicant]
US 20150118264A1 · Baumhof et al. · 2015 [cited by applicant]
US 20150165006A1 · Thess et al. · 2015 [cited by applicant]
US 20150184195A1 · Thess et al. · 2015 [cited by applicant]
US 20150218554A1 · Thess · 2015 [cited by applicant]
US 20150258214A1 · Baumhof et al. · 2015 [cited by applicant]
US 20150306249A1 · Baumhof et al. · 2015 [cited by applicant]
US 20150320847A1 · Thess et al. · 2015 [cited by applicant]
US 20160130345A1 · Fotin-Mleczek et al. · 2016 [cited by applicant]
US 20160166668A1 · Kallen et al. · 2016 [cited by applicant]
US 20160166678A1 · Kallen et al. · 2016 [cited by applicant]
US 20160166710A1 · Baumhof · 2016 [cited by applicant]
US 20160166711A1 · Schnee et al. · 2016 [cited by applicant]
US 20160168207A1 · Kramps et al. · 2016 [cited by applicant]
US 20160168227A1 · Kallen et al. · 2016 [cited by applicant]
US 20160206756A1 · Thess et al. · 2016 [cited by applicant]
US 20160235864A1 · Schlake et al. · 2016 [cited by applicant]
US 20160304883A1 · Grund et al. · 2016 [cited by applicant]
US 20160304938A1 · Wochner · 2016 [cited by applicant]
US 20160326575A1 · von der Mülbe · 2016 [cited by applicant]
US 20160331844A1 · Fotin-Mleczek et al. · 2016 [cited by applicant]
US 20170014496A1 · Fotin-Mleczek et al. · 2017 [cited by applicant]
US 20170029847A1 · Thess · 2017 [cited by applicant]
US 20170114378A1 · Wochner et al. · 2017 [cited by applicant]
US 20170239372A1 · Baumhof et al. · 2017 [cited by applicant]
US 20170252430A1 · Fotin-Mleczek et al. · 2017 [cited by applicant]
US 20170326225A1 · Rauch et al. · 2017 [cited by applicant]
US 20180044687A1 · Thess et al. · 2018 [cited by applicant]
US 20180078629A1 · Lorenz et al. · 2018 [cited by applicant]
US 20180125952A1 · Fotin-Mleczek et al. · 2018 [cited by applicant]
US 20180126003A1 · Hoerr · 2018 [cited by applicant]
US 20180142275A1 · Roos et al. · 2018 [cited by applicant]
US 20180147146A1 · Eber et al. · 2018 [cited by applicant]
US 20180148727A1 · Grund et al. · 2018 [cited by applicant]
US 20180201967A1 · Eber et al. · 2018 [cited by applicant]
US 20180207295A1 · Fotin-Mleczek et al. · 2018 [cited by applicant]
US 20180208957A1 · Roos et al. · 2018 [cited by applicant]
US 20180214537A1 · Mutzke et al. · 2018 [cited by applicant]
US 20180237786A1 · Schlake et al. · 2018 [cited by applicant]
US 20180237817A1 · Roos et al. · 2018 [cited by applicant]
US 20180243219A1 · Ketterer et al. · 2018 [cited by applicant]
US 20180256694A1 · Barner et al. · 2018 [cited by applicant]
US 20180296663A1 · Hipp et al. · 2018 [cited by applicant]
US 20180298372A1 · Funkner et al. · 2018 [cited by applicant]
US 20180312545A1 · Baumhof et al. · 2018 [cited by applicant]
US 20180371392A1 · Mayer et al. · 2018 [cited by applicant]
US 20190008954A1 · Baumhof · 2019 [cited by applicant]
US 20190010485A1 · Yazdan Panah et al. · 2019 [cited by applicant]
US 20190017100A1 · Wochner et al. · 2019 [cited by applicant]
US 20190024096A1 · Schmid et al. · 2019 [cited by applicant]
US 20190040378A1 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 20190049414A1 · Wochner et al. · 2019 [cited by applicant]
US 20190083602A1 · Roos et al. · 2019 [cited by applicant]
US 20190100784A1 · Eber et al. · 2019 [cited by applicant]
US 20190125857A1 · Rauch et al. · 2019 [cited by applicant]
US 20190133950A1 · Eber et al. · 2019 [cited by applicant]
US 20190151438A1 · Kallen et al. · 2019 [cited by applicant]
US 20190160164A1 · Rauch et al. · 2019 [cited by applicant]
US 20190177714A1 · Kunze et al. · 2019 [cited by applicant]
US 20190185859A1 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 20190194760A1 · Koch et al. · 2019 [cited by applicant]
US 20190225971A1 · Williams · 2019 [cited by applicant]
US 20190241633A1 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 20190249219A1 · Reichert et al. · 2019 [cited by applicant]
US 20190255161A1 · Thess et al. · 2019 [cited by applicant]
US 20190336608A1 · Baumhof et al. · 2019 [cited by applicant]
US 20190336611A1 · Baumhof et al. · 2019 [cited by applicant]
US 20190343933A1 · Horscroft et al. · 2019 [cited by applicant]
US 20190343942A1 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 20190345504A1 · Grund et al. · 2019 [cited by applicant]
US 20190351044A1 · Jasny et al. · 2019 [cited by applicant]
US 20190351047A1 · Jasny et al. · 2019 [cited by applicant]
US 20190351048A1 · Rauch · 2019 [cited by applicant]
US 20190365879A1 · Probst et al. · 2019 [cited by applicant]
US 20190381155A1 · Fotin-Mleczek et al. · 2019 [cited by applicant]
US 20190381180A1 · Baumhof et al. · 2019 [cited by applicant]
US 20200016264A1 · Hoerr et al. · 2020 [cited by applicant]
US 20200023076A1 · Fotin-Mleczek et al. · 2020 [cited by applicant]
US 20200040370A1 · Eber et al. · 2020 [cited by applicant]
US 20200085852A1 · Fotin-Mleczek · 2020 [cited by applicant]
US 20200085942A1 · Kramps et al. · 2020 [cited by applicant]
US 20200085943A1 · Baumhof et al. · 2020 [cited by applicant]
US 20200085944A1 · Heidenreich et al. · 2020 [cited by applicant]
US 20200149026A1 · Horscroft et al. · 2020 [cited by applicant]
US 20200163878A1 · Baumhof et al. · 2020 [cited by applicant]
US 20200179526A1 · Baumhof et al. · 2020 [cited by applicant]
US 20200216878A1 · Wochner · 2020 [cited by applicant]
US 20200246451A1 · Mutzke et al. · 2020 [cited by applicant]
US 20200268908A1 · Schnee et al. · 2020 [cited by applicant]
US 20200276336A1 · Thess et al. · 2020 [cited by applicant]
US 20200316189A1 · Kallen et al. · 2020 [cited by applicant]
US 20200318097A1 · Funkner et al. · 2020 [cited by applicant]
US 20200332293A1 · Thess · 2020 [cited by applicant]
US 20200338215A1 · Baumhof et al. · 2020 [cited by applicant]
US 20200383919A1 · Eber et al. · 2020 [cited by applicant]
US 20200383922A1 · Ketterer et al. · 2020 [cited by applicant]
US 20200392572A1 · Yazdan Panah et al. · 2020 [cited by applicant]
US 20200399322A1 · Baumhof et al. · 2020 [cited by applicant]
US 20210023199A1 · Kallen et al. · 2021 [cited by applicant]
US 20210030683A1 · Eber et al. · 2021 [cited by applicant]
US 20210030864A1 · Petsch et al. · 2021 [cited by applicant]
US 20210030866A1 · Kallen et al. · 2021 [cited by applicant]
US 20210040526A1 · Wochner et al. · 2021 [cited by applicant]
US 20210046179A1 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 20210060175A1 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 20210060181A1 · Thess et al. · 2021 [cited by applicant]
US 20210069315A1 · Baumhof et al. · 2021 [cited by applicant]
US 20210128716A1 · Thess et al. · 2021 [cited by applicant]
US 20210162037A1 · Jasny et al. · 2021 [cited by applicant]
US 20210170017A1 · Lutz et al. · 2021 [cited by applicant]
US 20210180106A1 · Wochner et al. · 2021 [cited by applicant]
US 20210187124A1 · Schlake et al. · 2021 [cited by applicant]
US 20210198649A1 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 20210205434A1 · Petsch et al. · 2021 [cited by applicant]
US 20210251898A1 · English et al. · 2021 [cited by applicant]
US 20210260178A1 · Jasny et al. · 2021 [cited by applicant]
US 20210261627A1 · Kramps et al. · 2021 [cited by applicant]
US 20210261897A1 · Yazdan Panah et al. · 2021 [cited by applicant]
US 20210308238A1 · Hoerr et al. · 2021 [cited by applicant]
US 20210361761A1 · Lutz et al. · 2021 [cited by applicant]
US 20210361764A1 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 20210369827A1 · Fotin-Mleczek et al. · 2021 [cited by applicant]
US 20210393755A1 · Thess et al. · 2021 [cited by applicant]
US 20210401966A1 · Rauch et al. · 2021 [cited by applicant]
US 20210401971A1 · Rauch · 2021 [cited by applicant]
US 20210403925A1 · Chevessier-Tünnesen et al. · 2021 [cited by applicant]
US 20220025369A1 · Fotin-Mleczek et al. · 2022 [cited by applicant]
US 20220040281A1 · Schwendt et al. · 2022 [cited by applicant]
US 20220073962A1 · Schwenger et al. · 2022 [cited by applicant]
US 20220090092A1 · Thess et al. · 2022 [cited by applicant]
US 20220096616A1 · Barner et al. · 2022 [cited by applicant]
US 20220119795A1 · Yazdan Panah et al. · 2022 [cited by applicant]
WO WO2002085434 · 2002 [cited by applicant]
WO WO2003059381 · 2003 [cited by applicant]
WO WO2009127230 · 2009 [cited by applicant]
WO WO2010037539 · 2010 [cited by examiner]
WO WO2010088927 · 2010 [cited by applicant]
WO WO2011008974 · 2011 [cited by applicant]
WO WO2011069528 · 2011 [cited by applicant]
WO WO2011069586 · 2011 [cited by applicant]
WO WO2011069587 · 2011 [cited by applicant]
WO WO2011144358 · 2011 [cited by applicant]
WO WO2012013326 · 2012 [cited by applicant]
WO WO2012019780 · 2012 [cited by applicant]
WO WO2012089338 · 2012 [cited by applicant]
WO WO2012113513 · 2012 [cited by applicant]
WO WO2012116810 · 2012 [cited by applicant]
WO WO2012116811 · 2012 [cited by applicant]
WO WO2013113501 · 2013 [cited by applicant]
WO WO2013113502 · 2013 [cited by applicant]
WO WO2013113736 · 2013 [cited by applicant]
WO WO2015101414 · 2015 [cited by applicant]
WO WO2015101415 · 2015 [cited by applicant]
WO WO2015101416 · 2015 [cited by applicant]
WO WO2015135558 · 2015 [cited by applicant]
WO WO2015149944 · 2015 [cited by applicant]
Agenbach et al., “Amino Acid Variation within the Fusion Protein of Respiratory Syncytial Virus Subtype A and B Strains during Annual Epidemics in South Africa”, [cited by applicant]
De Baets et al., “Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice,” [cited by applicant]
Declaration Under 37 C.F.R. § 1.132 by Benjamin Petsch submitted in U.S. Appl. No. 15/048,561, filed May 13, 2019. [cited by applicant]
Fleeton et al., “Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus,” [cited by applicant]
GenBank Accession AAX23994, fusion protein [human orthopneumovirus], 2005. [cited by applicant]
GenBank Accession HEMA_I34A1, RecName: Full=Hemagglutinin; Contain: RecName: Full=Hemagglutinin HA1 chain; Contains: RecName: Full=Hemagglutinin HA2 chain; Flags: Precursor, 2012. [cited by applicant]
Johnstone et al., “Shifting immunodominance pattern of two cytotoxic Tlymphocyte epitopes in the F glycoprotein of the Long strain of respiratory syncytial virus”, [cited by applicant]
Mani et al., “Codon optimization of the major antigen encoding genes of diverse strains of influenza A virus,” Interdiscip. Sci. Comput. Life Sci., 3:36-42, 2011. [cited by applicant]
Mottram et al., “Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus,” [cited by applicant]
Office Action issued in U.S. Appl. No. 15/048,561, mailed Aug. 29, 2016. [cited by applicant]
Office Action issued in U.S. Appl. No. 15/048,561, mailed Aug. 22, 2019. [cited by applicant]
Office Action issued in U.S. Appl. No. 15/048,561, mailed Feb. 8, 2018. [cited by applicant]
Office Action issued in U.S. Appl. No. 15/048,561, mailed Jan. 18, 2017. [cited by applicant]
Office Action issued in U.S. Appl. No. 15/048,561, mailed Jan. 11, 2019. [cited by applicant]
Office Action issued in U.S. Appl. No. 15/048,561, mailed Jun. 30, 2017. [cited by applicant]
Office Communication issued in corresponding EP Application No. 14761282, mailed on Feb. 28, 2019. [cited by applicant]
Office Communication issued in U.S. Appl. No. 16/781,781, mailed Oct. 28, 2020. [cited by applicant]
Office Communication issued in U.S. Appl. No. 16/781,781, mailed May 12, 2021. [cited by applicant]
Office Communication issued in U.S. Appl. No. 16/781,781, mailed Nov. 1, 2021. [cited by applicant]
PCT International Search Report and Written Opinion issued in International Application No. PCT/EP2014/002302, mailed Nov. 3, 2014. [cited by applicant]
Petsch et al., “Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection,” [cited by applicant]
Schlake et al., “Developing mRNA-vaccine technologies,” [cited by applicant]
Talaat et al., “A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses,” [cited by applicant]
Turner et al., “A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV,” [cited by applicant]